Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01563003 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism
A NA study, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT01563003: Completed NA study, sponsored by University of South Florida.
NCT01563003 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01563003, a NA study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Due to the considerable prevalence of anxiety in youth with autism spectrum disorders, this study seeks to establish the efficacy of a modified cognitive behavioral therapy protocol in 50 adolescents versus other available treatment options.
Primary Outcome
Scale range - 0 (minimum) to 25 (maximum). Higher scores represent worse anxiety symptom severity.
Interventions
- OTHER Cognitive Behavioral Therapy
- OTHER Treatment as usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT01563003 record still lists
NCT01563003 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT01563003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01563003 about?
NCT01563003 is a clinical study titled "Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism". Due to the considerable prevalence of anxiety in youth with autism spectrum disorders, this study seeks to establish the efficacy of a modified cognitive behavioral therapy protocol in 50 adolescents versus other available treatment options.
What is the current status of trial NCT01563003?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2011-06. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01563003?
The interventions under investigation include: Cognitive Behavioral Therapy (OTHER), Treatment as usual (OTHER).
Who is sponsoring clinical trial NCT01563003?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01563003's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia